Hemostasis and Coagulation
Plasma vs Serum
Blood Composition: Blood consists of various components, primarily plasma, which is the liquid portion, and cellular components such as erythrocytes (red blood cells), leukocytes (white blood cells), and platelets.
Plasma: A fluid rich in nutrients and cells, it can be separated from blood through centrifugation and contains:
Water
Proteins
Antibodies
Lipids
Carbohydrates (CHO)
Electrolytes, clotting factors, enzymes, vitamins, hormones
Serum: This is the fluid obtained after coagulated blood has been centrifuged, lacking fibrinogen due to its consumption during the coagulation process.
Blood Separation Layers
Blood is layered upon centrifugation:
Plasma: accounts for approximately 55% of total blood volume.
Buffy Coat: contains leukocytes and platelets, making up less than 1% of total blood volume.
Erythrocytes: constitute about 45% of total blood volume.
Hemostasis Overview
Definition of Hemostasis: The process that leads to the arrest of bleeding through the spontaneous formation of a hemostatic platelet plug.
Primary and Secondary Hemostasis
Primary Hemostasis:
Involves the formation of a hemostatic plug, initiated by platelet adhesion and aggregation, characterized by the following steps:
Platelet secretion
Platelet aggregation
Platelet adhesion
Shape change of platelets
Secondary Hemostasis:
Involves activation of the coagulation cascade resulting in the stabilization of the hemostatic plug through fibrin mesh formation.
Cascade Model vs. Cell Theory Model
Cascade Model: Depicts the sequential activation of coagulation factors leading to fibrin formation.
Cell Theory Model: Depicts coagulation as a cellular process occurring at the site of injury, emphasizing the roles of cells (like platelets) in the coagulation process.
Fibrinolysis
Definition of Fibrinolysis: The process that occurs after clot formation to dissolve the fibrin clot, restoring normal blood flow. It involves:
Activation of plasminogen to plasmin (primarily mediated by tissue plasminogen activator - tPA and urokinase plasminogen activator - uPA).
Detailed Hemostasis Phases
Primary Hemostasis Steps
Breach of Endothelium
Vasoconstriction: Reduction of blood flow to the injured area.
Platelet Adhesion: Platelets adhere to exposed collagen and von Willebrand factor (vWF).- facilitated by receptors GP Ib-IX-V and GP VI.
Release of Aggregators: Secretion of factors (such as ADP and thromboxane A2) that promote further platelet activation.
Platelet Aggregation: Platelet-to-platelet interactions, mediated by fibrinogen binding to activated GP IIb/IIIa receptors on platelets.
Platelet Plug Formation: Initially loose aggregation of platelets leading to the formation of a temporary hemostatic plug.
Secondary Hemostasis Steps
Coagulation Cascade Activation: Each factor in the cascade can be β-activated (as seen in the case of Factor VII to VIIa).
Fibrin Mesh Formation: Thrombin (Factor IIa) converts fibrinogen to fibrin, stabilizing the platelet plug through the formation of covalent cross-links, aided by Factor XIII (Fibrin Stabilizing Factor).
Interaction and Regulation Mechanisms
Anticoagulant Factors:
Prostacyclin (PGI2): Inhibits platelet activation, produced by endothelial cells.
Tissue factor pathway inhibitors (TFPIs): Inhibit coagulation factor actions to prevent undue clot formation.
Thrombomodulin: When bound to thrombin, it activates Protein C, leading to the degradation of Factors Va and VIIIa and slowing the coagulation process.
Procoagulant Factors: Factors that promote clotting, including platelets, collagen, and thrombin activators (e.g., the extrinsic pathway begins with tissue factor).
Major Plasma Coagulation Factors
Fibrinogen (I): Main structural protein for fibrin clot, converted by thrombin.
Prothrombin (II): Converted to thrombin during the coagulation process, mediates various hemostatic functions.
Tissue Factor (III): Activates the extrinsic pathway, leads to activation of Factor VII.
Calcium (IV): Essential cofactor for several steps in coagulation.
Factors V, VII, VIII, IX, X, XI, XII, XIII: Each plays a critical role in the coagulation cascade, with specific functions and interactions.
Summary of Coagulation Factors
Each coagulation factor has a unique role, with some functioning as zymogens (inactive form), while others as co-factors or substrates that are necessary for the coagulation cascade to progress effectively.
Their activation generally follows a predetermined sequence, leading to eventual fibrin clot formation and stabilization through cross-linking.
Fibrinolysis Process
Post clot formation, the process of fibrinolysis begins:
tPA/UPA activate plasminogen which hydrolyzes fibrin and fibrinogen leading to their breakdown.
Resulting fibrin degradation products (FDPs) include D-dimer, indicating clot breakdown.
Clinical Relevance
Disorders that affect primary and secondary hemostasis can lead to serious bleeding disorders, such as hemophilia, characterized by deficiencies in specific coagulation factors (e.g., Factors VIII or IX).
Conclusion
Understanding the intricacies of hemostasis and the role played by each component is essential for diagnosing and treating clotting disorders and managing bleeding complications in clinical settings.